CDH1 and breast cancer: Since BC cell lines with high/moderate BCAR4 mRNA expression featured CDH1/E-cadherin mutations, this tumor series was enriched for lobular carcinomas, which lack E-cadherin due to mutation or epigenetic inactivation (Table 1) [27].